Retina-Vitreous Associates Medical Group Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Retina-Vitreous Associates Medical Group's estimated annual revenue is currently $41.6M per year.(i)
  • Retina-Vitreous Associates Medical Group's estimated revenue per employee is $297,000

Employee Data

  • Retina-Vitreous Associates Medical Group has 140 Employees.(i)
  • Retina-Vitreous Associates Medical Group grew their employee count by 24% last year.

Retina-Vitreous Associates Medical Group's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Copy EditorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.7M5-81%N/AN/A
#2
$17M70-4%N/AN/A
#3
$4.9M264%N/AN/A
#4
$10.2M4718%N/AN/A
#5
$0.7M5-92%N/AN/A
#6
$66.2M2239%N/AN/A
#7
$12.6M5227%N/AN/A
#8
$53.2M179-2%N/AN/A
#9
$5.1M27-10%N/AN/A
#10
$22.1M824%N/AN/A
Add Company

What Is Retina-Vitreous Associates Medical Group?

Retina-Vitreous Associates specializes in the treatment of diseases affecting the back of the eye, specifically those of the retina, vitreous, and macula. Patients are typically referred by their general ophthalmologist when a retinal problem is suspected. We care for patients with macular degeneration, diabetic retinopathy, retinal detachment, retinal vein occlusions, uveitis, ocular tumors and pediatric retinal diseases. We have six office locations. Each is equipped with state of the art diagnostic equipment and treatment facilities. Our group is also extremely active in clinical research, community education and participates in a number of various clinical studies evaluating new treatments. We are dedicated to providing the best possible care, and can provide patient access to the most current treatment options.

keywords:Healthcare

N/A

Total Funding

140

Number of Employees

$41.6M

Revenue (est)

24%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Retina-Vitreous Associates Medical Group News

2022-04-13 - Retina Consultants of America Announces 25th Alliance in ...

Vitreo Retinal Surgeons and Gulf Coast Retina Associates Partnership ... The physicians and staff of Retina Group of Florida would like to...

2022-04-06 - Adverum Biotechnologies Proceeds with IND Amendment for ADVM-022 Phase 2 Trial in Wet AMD After Receiving Requested Type C Meeting Feedback from the FDA

... a clinical-stage gene therapy company targeting unmet medical needs ... M.D., physician at Retina-Vitreous Associates Medical Group and...

2022-03-30 - Outlook Therapeutics submits Biologics License Application to ...

... MD, Retina-Vitreous Associates Medical Group, Assoc. Clinical Professor of Ophthalmology, UCLA School of Medicine, said in a statement.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$47M14023%N/A
#2
$41.6M1409%N/A
#3
$37.9M140-6%N/A
#4
$23.1M1401%N/A
#5
$15M1406%N/A